Published in Cancer Weekly, December 6th, 2005
"In this study we have examined the cytotoxic effects of different concentrations of Ado and dAdo on human breast cancer cell lines. Ado and dAdo alone had little effect on cell cytotoxicity," scientists writing in the journal Cell Proliferation reported.
"However, in the presence of adenosine deaminase (ADA) inhibitor, EHNA, adenosine and deoxyadenosine led to significant growth inhibition of cells of the lines tested. Ado/EHNA and dAdo/EHNA-induced cell death was significantly inhibited by NBTI, an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.